High-grade serous ovarian carcinoma is the most common and most lethal histological subtype of epithelial ovarian cancer, in which the development of resistance to platinum-based chemotherapy represents a major clinical challenge. The aim of this master’s thesis was to evaluate the effects of selected agonists, antagonists and selective modulators of the progesterone receptor on the viability and migration of chemosensitive OVSAHO and chemoresistant COV362 cells. RT-qPCR was used to determine the expression of the PGR gene and genes involved in progesterone metabolism, while the presence of PR-A and PR-B protein isoforms was assessed by Western blotting. Cell viability was determined using the AlamarBlue™ assay and migration using the wound-healing assay. The PGR gene was expressed in both cell lines, whereas PR-A and PR-B isoforms were below the detection limit. Differences in the expression of AKR1C1–3 and SRD5A1 suggest that progesterone metabolism may differ between OVSAHO and COV362 cells, with preferential formation of 5α-pregnanes in OVSAHO and 4-pregnenes in COV362 cells. Among the agonists, progesterone at nanomolar concentrations had no effect on cell viability, whereas at 10 μM it significantly increased viability in COV362 cells. MPA reduced the viability of both cell lines at higher concentrations, whereas levonorgestrel had no significant effect. The antagonist mifepristone and the selective modulator UPA reduced cell viability, with a particularly pronounced effect on wound closure in COV362 cells, where they caused almost complete inhibition of wound closure already at 1 μM. The effects of the investigated compounds depended on their concentration and the cell model. Because expression of the classical nuclear progesterone receptor was not detected at the protein level, the results raise the possibility that the observed effects are mediated by other progesterone receptors. Further mechanistic studies will be required to clarify their role.
|